Everand Logo

Welcome to Everand!

  • Discover millions of ebooks, audiobooks, and so much more with a free trial

    Only $11.99/month after trial. Cancel anytime.

    Unavailable
    Lean Biomanufacturing: Creating Value through Innovative Bioprocessing Approaches
    Unavailable
    Lean Biomanufacturing: Creating Value through Innovative Bioprocessing Approaches
    Unavailable
    Lean Biomanufacturing: Creating Value through Innovative Bioprocessing Approaches
    Ebook554 pages5 hours

    Lean Biomanufacturing: Creating Value through Innovative Bioprocessing Approaches

    By Nigel J Smart

    ()

    Currently unavailable

    Currently unavailable

    About this ebook

    With decreasing profit margins, increasing cost pressures, growing regulatory compliance concerns, mounting pressure from generic drugs and increasing anxiety about the future of healthcare reimbursement, pharmaceutical manufacturers are now forced to re-examine and re-assess the way they have been doing things. In order to sustain profitability, these companies are looking to reduce waste (of all kinds), improve efficiency and increase productivity. Many of them are taking a closer look at lean manufacturing as a way to achieve these goals. Lean biomanufacturing re-visits lean principles and then applies them sympathetically - in a highly practical approach - to the specific needs of pharmaceutical processes, which present significantly different challenges to more mainstream manufacturing processes. A major goal of the book is to highlight those problems and issues that appear more specific or unique to biopharmaceutical manufacturing situations and to provide some insights into what challenges are the important ones to solve and what techniques, tools and mechanisms to employ to be successful.Following an introduction to lean biomanufacturing, the book goes on to discuss lean technologies and methods applied in biomanufacturing. Later chapters cover the creation and implementation of the Transition Plan, issues facing the biopharmaceutical industry, creating a lean approach towards biopharmaceutical processes and the contribution of simulation models in developing these processes. The final chapter covers examples of new technology innovations which help facilitate lean biomanufacturing.
    • A focus on the issues associated with the application of lean principles to biomanufacturing
    • Practical examples of factors which can affect biopharmaceutical processes
    • Coverage of key factors which require integration to run an efficient biopharmaceutical process
    LanguageEnglish
    PublisherElsevier Science
    Release dateOct 31, 2013
    ISBN9781908818409
    Unavailable
    Lean Biomanufacturing: Creating Value through Innovative Bioprocessing Approaches
    Author

    Nigel J Smart

    Nigel J. Smart PhD is a 30 year veteran of the biotechnology industry who has spent his career involved in developing and manufacturing numerous recombinant protein, monoclonal antibody and vaccine products. He holds a BSc from the University of Leicester, and an MSc and PhD in Fermentation Technology/Biochemical Engineeringfrom the University of Manchester. His career has spanned academia, Big Pharma and progressive biotechnology companies involved in cutting-edge biopharmaceutical products. For the last eleven years he has been a much sought-after consultant solving operational problems and compliance related issues to the pharmaceutical and biopharmaceutical industry. This has also included advising the US government on manufacturing strategies to produce a variety of biological countermeasures for the biodefense program. As Managing Partner of Smart Consulting Group, Dr Smart is now a proponent of lean approaches to biopharmaceutical manufacturing processes and leads the company’s business team in this area.

    Related to Lean Biomanufacturing

    Related ebooks

    Science & Mathematics For You

    View More
    View More

    Related podcast episodes

    Related articles

    • Article

      Indian Pharma's Big Leap

      Apr 30, 2018

      Indian Pharma's Big Leap
      6 min read

    • Article

      Opinion: Diagnostic Innovations Are Slowed By Bureaucratic Roadblocks

      Jan 18, 2019

      It's a long and winding road to bringing diagnostic innovations to the U.S. market. We need to clear the roadblocks.

      5 min read

    • Article

      Opinion: Digital Health Startups May Not Want To Do Randomized Trials, But They Need To

      Oct 15, 2018

      Digital health is a fast-moving field that's impeded by the slow timelines of clinical research organizations and top medical journals. They need to pick up the pace.

      4 min read

    • Article

      Opinion: FDA Is Smashing The Status Quo For Regulatory Science

      Oct 14, 2019

      The FDA can enable innovation by being a partner in advancing new approaches to drug development and regulatory science. Its recent reorganization signals a revolutionary shift in regulatory velocity.

      5 min read

    • Article

      Opinion: 10 Reasons Why Health Care Startups Fail

      Feb 10, 2020

      Here are 10 of the most common problems we've seen that can cause a health care startup to fail and some tips to solve them.

      6 min read

    • Article

      A Commitment To Best Practice

      Feb 10, 2020

      Few retailers or brand owners will consider doing business with a supplier that does not have certification to a global standard. Certification helps a business improve its product, management systems, quality control and overall competitiveness. The

      2 min read

    • Article

      What Is Ethical Manufacturing And Why Is It So Important?

      Sep 10, 2021

      Businesses have a big impact on their community, whether that involves how they care for the environment or how they contribute to the lives of their staff. This is particularly true for manufacturers. Their presence is vital in supporting communitie

      3 min read

    • Article

      Opinion: Synthetic Control Arms Can Save Time And Money In Clinical Trials

      Feb 5, 2019

      Synthetic control arms aren't the solution to all of the challenges facing randomized trials, but they represent a great way for drug development companies to start using real-world evidence.

      4 min read

    • Article

      The Era of Human + Machine Innovation

      Jan 1, 2019

      Interview by Karen Christensen In today's environment, organizations that don't keep up with customers' evolving needs are doomed. What is the best way to get a handle on these evolving needs? The first step in understanding your customers is to acce

      5 min read

    • Article

      Opinion: From Bench To Bedside, Biologics Require Excellence At Every Stage

      Feb 13, 2020

      Quality and trust go together. As an industry, biologic manufacturers must deliver on quality. Public trust of sophisticated biological products will follow.

      3 min read

    • Article

      Opinion: Manufacturing: The Next Breakthrough In Gene Therapy

      Dec 18, 2019

      As the race heats up to bring gene therapy to market, breakthroughs in manufacturing are often the key — or break down the barrier — to delivering these therapies to…

      3 min read

    • Article

      Opinion: Why Health Companies Are Branding Themselves As Tech Companies

      Aug 1, 2019

      The trend of health care startups branding themselves as technology companies should prompt the health care industry to engage in serious self-reflection.

      4 min read

    • Article

      Opinion: The FDA Needs To Set Standards For Using Artificial Intelligence In Drug Development

      Nov 7, 2019

      Poorly constructed AI algorithms for drug discovery and testing have the potential to cause harm. The FDA should play an important role in ensuring that AI-based drug development tools meet…

      3 min read

    • Article

      Know Before Your Inspection

      Jun 22, 2020

      Know Before Your Inspection
      2 min read

    • Article

      Opinion: Realizing The Promise Of Prescription Digital Therapeutics

      Oct 29, 2019

      Prescription digital therapeutics will be a key piece of the emerging global digital market, which may be worth more than half a trillion dollars by 2025.

      3 min read

    • Article

      Disrupting the Healthcare System

      Jan 1, 2020

      What are the biggest wicked problems in healthcare right now? There are several, and from my perspective they are driven by two factors. The first is that there are so many stakeholders involved, which often means that there is no one ‘right’ solutio

      7 min read

    • Article

      Growing Greener

      Mar 20, 2020

      Growing Greener
      8 min read

    Related categories

    Reviews for Lean Biomanufacturing

    0 ratings

    0 ratings0 reviews

    What did you think?

    Tap to rate

    Review must be at least 10 words